04/27/2021

Deciphera Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 4, 2021

03/31/2021

China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)

03/02/2021

Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference

03/02/2021

Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference

02/18/2021

Deciphera Pharmaceuticals, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference

02/09/2021

Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results

02/04/2021

Deciphera Pharmaceuticals, Inc. to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day

02/02/2021

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on February 9, 2021

02/02/2021

Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on February 9, 2021

01/11/2021

Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones